Furthermore, IL-1β can stimulate IL-6 production in tissue transglutaminase 2-overexpressing MCF-7 cells through an NF-kB-, PI3K- and JNK-dependent mechanism, which represents a critical survival signal for BC stem cells, leading to in vivo tumorigenesis and drug resistance [207,208]. Here, IL6 is linked to breast cancer.